OL-CD19-GDT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OL-CD19-GDT, covering 2025-09-11 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases [Phase 1]